These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11966448)

  • 1. Selective PGHS-2 inhibitors: a rational approach for treatment of the inflammation.
    Rodrigues CR; Veloso MP; Verli H; Fraga CA; Miranda AL; Barreiro EJ
    Curr Med Chem; 2002 Apr; 9(8):849-67. PubMed ID: 11966448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.
    Pouplana R; Lozano JJ; Pérez C; Ruiz J
    J Comput Aided Mol Des; 2002 Oct; 16(10):683-709. PubMed ID: 12650588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
    Pouplana R; Lozano JJ; Ruiz J
    J Mol Graph Model; 2002 Jan; 20(4):329-43. PubMed ID: 11858641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double His513 --> Arg and Ile523 --> val mutation.
    Wong E; Bayly C; Waterman HL; Riendeau D; Mancini JA
    J Biol Chem; 1997 Apr; 272(14):9280-6. PubMed ID: 9083063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analysis of nonsteroidal antiinflammatory drug selectivity in prostaglandin G/H synthase (PGHS)-null cells.
    Kirtikara K; Swangkul S; Ballou LR
    Inflamm Res; 2001 Jun; 50(6):327-32. PubMed ID: 11475335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents.
    Guo Q; Wang LH; Ruan KH; Kulmacz RJ
    J Biol Chem; 1996 Aug; 271(32):19134-9. PubMed ID: 8702589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of some PGHS-2 selective inhibitors with the PGHS-1: an automated docking study by BioDock.
    Pedretti A; Villa AM; Villa L; Vistoli G
    Farmaco; 1997; 52(6-7):487-91. PubMed ID: 9372601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs.
    DeWitt DL; Meade EA; Smith WL
    Am J Med; 1993 Aug; 95(2A):40S-44S. PubMed ID: 8357002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
    Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
    Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs.
    Smith WL; DeWitt DL
    Semin Nephrol; 1995 May; 15(3):179-94. PubMed ID: 7631045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of PGH synthase isozymes-1 and -2 with NSAIDs.
    Smith WL; Meade EA; DeWitt DL
    Ann N Y Acad Sci; 1994 Nov; 744():50-7. PubMed ID: 7825862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naphthalene derivatives: A new series of selective cyclooxygenase-2 inhibitors.
    Feixas J; Jiménez JM; Godessart N; Puig C; Soca L; Crespo MI
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2687-90. PubMed ID: 11591502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2.
    Smith WL; Meade EA; DeWitt DL
    Ann N Y Acad Sci; 1994 Apr; 714():136-42. PubMed ID: 8017762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
    Chulada PC; Langenbach R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibitors of COX-2.
    O'Neill GP; Kennedy BP; Mancini JA; Kargman S; Ouellet M; Yergey J; Falgueyret JP; Cromlish WA; Payette P; Chan CC
    Agents Actions Suppl; 1995; 46():159-68. PubMed ID: 7610986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs.
    Patrignani P; Panara MR; Sciulli MG; Santini G; Renda G; Patrono C
    J Physiol Pharmacol; 1997 Dec; 48(4):623-31. PubMed ID: 9444611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1.
    Glaser K; Sung ML; O'Neill K; Belfast M; Hartman D; Carlson R; Kreft A; Kubrak D; Hsiao CL; Weichman B
    Eur J Pharmacol; 1995 Jul; 281(1):107-11. PubMed ID: 8566109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
    Lesch CA; Gilbertsen RB; Song Y; Dyer RD; Schrier D; Kraus ER; Sanchez B; Guglietta A
    J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs.
    Curnock AP; Robson PA; Yea CM; Moss D; Gadher S; Thomson TA; Westwood R; Ruuth E; Williamson RA
    J Pharmacol Exp Ther; 1997 Jul; 282(1):339-47. PubMed ID: 9223572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2: a therapeutic target.
    Turini ME; DuBois RN
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.